One of the most exciting things about living in the genome sequencing era is that hitherto intractable pathogens can be understood for the first time in unimaginable detail. Many bacterial genomes have been sequenced and one can now enquire about their physiology. 1t is possible not just to enquire about Mycobacterium leprae, but make comparisons with other host-dependent and axenicalIy uncultivable pathogens 1 such as Treponema pallidum, that have also had their genomes sequenced.
Previously, to study the metabolism and biochemistry of leprosy bacilli one had to purify them fram the heavily infected tissues of armadilIos or nude mice. Some data were obtained fram less heavily infected sources induding even human biopsies but from such limited material only very limited data could be obtained. To be able to start to deduce metabolic pathways in operation, greater numbers of leprasy bacilli fram more heavily infected tissue were needed ? Regardless of the source, it was always essential to prave that any metabolic activity was fram the bacteria, and not contamination from the host. For example, catalase activity is readily detected in suspensions and extracts of leprosy bacilIi but biochemical 3 and genetic 4 , 5 analysis show that this was host-derived, and there was no mycobacterial KatG (see Box 1) catalase activity. AlI this was difficult, but perhaps on balance easier than having to extract bacteria fram rabbit testides as is the case for the aforementioned agent of syphilis, T. pallidum.
Now there is genome data to mine. The truth is in there, ar rather predictions of the truth are. It is important to keep in mind that deducing a function for a gene (that is, to give an example, referring to ML2323 as ask, the gene for aspartokinase) are predictions of function made on the basis of similarities to raw sequence information elsewhere in nature. Many of the similarities are so high, and so consistent throughout a metabolic pathway, that the attributions are essentially incontestable. These have been compiled into metabolic pathways in the KEGG database (http://www.genome.ad.jp/kegg/) where, for example, the nudeotide biosynthetic pathways referred to in Box 1 can be viewed. Other areas of metabolism are still Box 1. The physiology of Mycobacterium leprae as deduced from its genome
• Uniquely for a host-dependent pathogen, the biosynthetic pathways for purine and pyrimidine nucleotides are complete.
• Biosynthetic pathways for lipids and amino acids are also complete with the exception that M. leprae is a methionine auxotroph.
• Only central pathways of carbon and energy metabolism are complete but alternative pathways are degenerate.
• The co-enzyme central to the most universal metabolic pathways -NADH cannot be recycled to NAD by the usual oxidative respiratory route.
• Redundancy seen in M. tuberculosis is often lost in M. lepra e, as most paralogues seen in M. tuberculosis are pseudogenes (= non-functional) in M. leprae.
• Defence against toxic radicais is severely degenerate, as neither katG nor the narGHJI cluster is functional.
• None of the few (1 42) additional genes only found in M. leprae appear to confer additional metabolic pathways.
far from c1ear. Some of these are explored in this review, such as whether M. leprae is capable of the biosynthesis of siderophores for the vital activity of acquisition of iron from the environment. This is but one example of how the genomic data generates hypotheses to be tested. There are yet others to be generated. The 'take-home message' is that the genome sequence is not the conc1usion of research into any particular microbe, but merely the 'end of the beginning', a beginning started with rational research on microbial metabolism and the action of antimicrobial agents by Pasteur, Entner and Doudoroff, Stamp and Green amongst others. 6 The big questions in bacterial physiology are: how do bacteria obtain their nutrition, use it for production of energy (catabolism) and make all their components -proteins, lipids, cell envelope, nuc1eic acids and so on (anabolism). The first four points in Box 1 summarize how the genome project has shown how M. leprae differs from other microbes in general, while the fifth point shows how M. leprae differs from My cobacterium tuberculosis in particular.
Microbes of medical interest vary considerably in their metabolic capabilities. At one extreme, some are autotrophs so that they can make everything they need from ammonium ions and carbon dioxide. At the other extreme, there are highly host-dependent organisms such as Rickettsia and treponeme species. 1 A c1assical example of their dependency upon the host for preformed intermediates is that they are unable to synthesize the structures on which nuc1eotides are based -purine and pyrimidine rings that inc1ude four to tive carbon atoms and two to five nitrogen atoms. Thus, like many parasitic microbes, they have to scavenge purines and pyrimidines from their host. Intuitively, M. leprae would be expected to lie on the host dependent end of this scale, since it cannot be grown axenically and it grows almost by stealth when it is in the host, dividing no more rapidly than every 12 days (growth rate -0.0035 h -I ) .7 However, a surprising tinding from the genome sequence is that M. leprae has the capacity to make most of its own components. For example, although it is able to obtain lipids, amino acids, purines and pyrimidines directly from the host, 4 it can also make all these from the simplest components. ln this respect its metabolism is no different from E. coZi or M. tuberculosis. The one exception is that M. leprae cannot make methionine and must depend upon the host for this one amino acido This one piece of degeneracy in the major anabolic pathways is evidently something that pathogenic mycobacteria can tolerate, since experimentally obtained methionine auxotrophs of M. tuberculosis show little or no attenuation. 8 , 9
Compare now in Table 1 the difference between the distribution of genes for the anabolic pathways I have just mentioned and those for energy metabolismo The former are virtually complete, with losses in M. leprae compared with M. tuberculosis being down to loss of redundancy more often than function. Thus, whereas M. tuberculosis may have two or more genes capable of performing a particular function, M. leprae frequently has just one. Even in the case of lipid biosynthesis, central pathways are complete with the losses reflecting the more limited, but still extensive, repertoire of lipids produced by M. leprae. However, for energy metabolism (catabolism) M. leprae has less than one-third the functional genes possessed by M. tuberculosis. Here, alternative pathways are lost and M. leprae has a very limited aerobic respiratory metabolismo It is possible for M. leprae to use glucose or glycerol or even pyruvate, catabolizing them to carbon dioxide to generate ATP oxidatively ( Figure 1 ). However, the rate at which pyruvate is converted to acetyl-CoA to feed carbon into the oxidative Krebs cyc1e (Figure 1 ) is limited by a loss of redundancy. The pdh genes found in M. tuberculosis are lost in M. leprae and the function -the corresponding enzymatic activity -is markedly 10w. 1O This remaining function is apparently encoded by aceE and lp d, two separate genes that are ML 1651 and ML2387, respectively. Disregarding the rate of catabolism of glucose and glycerol to carbon dioxide, their oxidation is predicted to generate only about 35% the ATP per mole carbon source oxidized that analogous pathways in M. tuberculosis generate, since all the NAD is predicted to be recycled in an oxygen independent way (Figure 1 ). This faiIure to coupIe NADH oxidation to electron transport appears to be an adaptation to low oxygen tension yet the anaerobic respiratory systems seen in M. tuberculosis are alI gone in M. leprae. Finally, the inabiIity to recycle acetate (Figure 1 ) is predicted to lessen opportunities for axenic growth by limiting the number of carbon sources that M. leprae can use. 11
Other notable differences between M. leprae and M. tuberculosis occur in the anaplerotic pathways in which 3-carbon (pyruvate, phospho-enol-pyruvate or PEP) and 4-carbon compounds (e.g. oxaloacetate, malate) can be interconverted to be used in either a catabolic or anabolic direction (Figure 1) . Here, M. leprae lacks the pca gene. This is predicted to be required for pyruvate to be used in gluconeogenesis in groups of organisms that posses pca, such as actinomycetes and yeasts; thus another component of carbon metabolism is lacking in to pyruvate is shown twice for clarity. For M. leprae, it follows that glucose and glycerol can be used for both ATP generation and gluconeogenesis to lead to cell wall intermediates as black arrows can be followed throughout the pathways. Pyruvate can only be used to generate ATP in the pathways shown in this figure, and acetate and galactose cannot be used at alI. Ali substrates can be used in ali directions by tubercle bacilli.
M. leprae. Intriguingly, M. leprae has a gene not present in M. tuberculosis, ppc (Figure 1) . It is hard to predict the function of ppc, with certainty. Possibly it would allow oxaloacetate to be topped up so that the citric acid cyc1e could continue through dismutation of PEP (Figure 1 ). The effects of these differences should be ascertained by comparing the metabolic fate of pyruvate, glycerol, and perhaps other carbon sources (see Figure 1 for examples) in M. leprae and other actinomycetes.
A further enzyme in interconverting 3-and 4-carbon compounds is malic enzyme (decarboxylating), which converts malate to pyruvate. The dichotomy between fast and slow growing mycobacteria was once thought to be based, with few exceptions, on the presence or absence of this enzyme, with its activity found only in fast growers (mycobacteria that have a growth rate of above about 0. 15 h-I ). Intriguingly the corresponding gene, mez, is actually found in M. tuberculosis (Rv2332), but is a pseudogene in M. leprae. Together with the apparent 'pinch-point' for conversion of pyruvate to acetyl-CoA mentioned above, this may reftect an irreversible commitment of M. leprae to a lifestyle characterized by slow growth and necessarily slow central metabolismo
The overall conc1usion is that loss of altemative pathways in catabolism and also the loss Intracellular pathogens such as M. leprae and M. tuberculosis have to protect themselves from exposure to toxic products produced by host macrophages. M. leprae lacks major components of its defences against the highly toxic and damaging oxygen-and nitrogen-free radicaIs. Against oxygen radicais there is no functional katG to encode catalase. This is evident from the genome sequence and has been proved biochemically 3 and genetically. 4 . 5
The narGHJI gene c1uster, 1 2 which is lacking in M. leprae, may be a virulence factor, and could be involved in resistance against nitrogen oxide radicaIs. Their deletion, together with the lack of a functional katG to encode catalase as a defence against oxygen-free radicaIs, makes M. leprae look very vulnerable to the host' s cell defence mechanisms. This reduction in the genes for respiration and to deal with the consequences of an oxygen-rich environment may therefore reftect a niche with relatively constant conditions (intracellular, little toxicity, a fairly constant microaerophilic environment) for M. leprae. ln contrast, M. tuberculosis exists in a variety of tissues, from intracellular when it has been engulfed by alveolar macrophages, to caseated, probably almost anaerobic, Iesions. Extreme specialization of the leprosy bacillus in terms of its oxygen environment may account for the deletion or inactivation in the M. leprae genome of 145 of the 170 remaining oxidoreductases and oxygenases found in M. tuberculosis.
Iron acquisition and metabolism
Classical studies show that the ability to acquire iron from the host is essential for the survival and growth of intracellular pathogens. Yet in comparison with M. tuberculosis M. leprae appears to have a major deficiency in its ability to acquire iron. Its entire mbt operon is deleted, rendering it unable to make either the membrane-associated or excreted form of mycobactin T. ln M. tuberculosis, such a deletion would lead to loss of virulence as deletion of the mbtB gene results in restriction of growth in iron-limited media and in macrophages. 1 3 However, suspensions of M. leprae do not take up iron from the excreted mycobactin siderophores of slow-growing mycobacteria inc1uding M. tuberculosis and My cobacterium avium. Instead, they acquire iron from the exochelin siderophores of My cobacterium neoaurum, one of the most rapid-growing and least fastidious mycobacteria, and an unc1assified, cultivable, armadillo-derived mycobacterium. Although they share the function of iron acquisition, these two types of siderophores are chemically distinct. While mycobactin T is derived from salicylate, the exochelins are hydroxymate-derived side rophores. 14 Thus, maybe it is the genes for a hydroxymate-based siderophore that should be searched for in the M. leprae genome. The genes for the biosynthesis, and probably the export and uptake of the exochelin of M. smegmatis are known. 1 5 The fx b genes for biosynthesis have no strong matches in the M. leprae or M. tuberculosis genomes even though one would predict that M. leprae would synthesize the c1ass of siderophore that it can transport. However, there are important differences between the exochelins of M. smegmatis and M. neoaurum (for example the use of D-omithine and N-methylation in the M. noeaurum in contrast to L-omithine and N-formylation in M. smegmatis) (see 14 for a comparison of the fulI structures) so alI the similarity one might expect to see in the genes could be peptide synthases. Thus it is difficult to deduce whether M. leprae possesses functional genes for siderophore biosynthesis. However, it might be more feasible to search for genes involved in their transport. ln M. smegmatis, fx uD is regarded as the gene encoding the ferri-siderophore receptor, but while this has 36% identity to the M. tuberculosis fe cB2 gene for an iron transport protein (Rv0265c), the corresponding gene (ML2548) in the M. leprae genome is a pseudogene. A c1uster of three orfs immediately downstream of the M. smegmatis exochelin biosynthesis locus have strong similarity to c1usters of three orfs (in both M. tuberculosis (Rv 1458c to Rv 1456c) and M. leprae (ML0589 to ML0591) but in both pathogens these appear neither to be under iron regulation nor ftank:ed by genes likely to be involved in iron metabolismo While the genes involved in iron acquisition by the leprosy bacillus remain obscure, there is no doubt that M. leprae does utilize iron. The presence of genes for cytochrome c (ccsA,B) , a haemoglobin-like oxygen carrier (glbO), ferredoxin ifdx C, D), biosynthesis of the haem group (hem genes) and for the iron-storage bacterioferritin bfrA (in one of the many examples of loss of redundancy, a second, bfrB gene present in M. tuberculosis is deleted from M. leprae) are alI examples of genes encoding iron-containing molecules. Finally, IdeR, the key iron regulation protein dependent on intracelIular iron, is highly conserved, with 84% identity to the M. tuberculosis IdeR. As in M. tuberculosis, ideR is just downstream of another important regulator, sigB, which is involved in response to stress and growth in macrophages. The capacity of M. leprae to tightly regulate intracelIular iron would be anticipated to be vital since its katG, the gene that encodes the major catalase activity of pathogenic mycobacteria, is a pseudogene. Thus an excess of iron that would catalyse the formation of peroxides and oxygen-free radicaIs would be especialIy disastrous for the leprosy bacilIus, and just as harrnfu l to the bacterium as iron deficiency.
Do the genes found only in M. leprae expIain its neurotropism?
Two distinctive properties of M. leprae are its ability to invade and grow in peripheral nerves, and its production of a unique phenolic glycolipid that forms a capsule around the bacilIus. These properties are now thought to be link:ed, as the phenolic glycolipid binds to peripheral nerves. This lipid binds to the basal lamina of Schwann celI axons in a specific way that is inhibited by both (neural) laminin fragments and the trisaccharide moiety of the glycolipid. 1 6 Another product that is involved in binding to Schwann cells is the laminin binding protein, Lbp, though this is found in other mycobacteria. 17 The phenolic glycolipid is unique because it has a unique trisaccharide moiety, whereas other similar glycolipids, such as the one found in M. bovis, have a single sugar. IS The genes for adding the additional sugars have not been identified yet, 4 but the 142 genes specific to M. leprae are not candidates since they are too short to encode for the required glycosyltransferases enzymes. However, some of the apparent gene fragments amongst the 142 specific genes could be large enough to encode neuroactive peptides.
Genes found in M. leprae but not in M. tuberculosis, for which it has been possible to attribute functions, are shown in Table 2 . It is hard to implicate any of them in neurotropism but they do appear to be involved in uptake and metabolismo The adenyl cyc1ase and nramp homologues (ML234l and ML2667, respectively) may suggest unusual regulatory functions, perhaps related to a predilection of the leprosy bacillus for adenosine, a property predicted by c1assical biochemical studies. 1 9 A possible link that emerges fiom the M. leprae genome is that while most of the genes for making cobalamin and related vitamins have been lost in M. leprae, most of the few that remain use adenosine or its derivatives as one of their substrates. While the genes for making cobalarnin are in M. tuberculosis, another of the genes found only in M. leprae (uridine phosphorylase) encodes an enzyme in pyrirnidine nuc1eotide metabolismo There is something unusual about this whole area of purine and pyrirnidine metabolism in M. leprae. Why should the biosynthetic pathways have been retained in such a host-dependent pathogen? Maybe it is part of the mechanism that allows the leprosy bacillus to survive and grow within the rather metabolically inert Schwann ce1ls. Most leprosy bacilli that have been used for biochernical work were obtained from established infections in macrophages (spleens, lymph nodes and livers of experimentally infected armadillos 2 ). ln such established macrophage infections, biochernical studies showed that M. leprae only uses scavenging pathways typical of obligate parasites and not the de novo purine biosynthesic pathways 2 0 of which it is capable according to its genome. It is possible that the de novo purine biosynthetic pathway is required to establish infection if the early stages are analogous to M. tuberculosis infections in which purC mutants in the de novo pathway are cleared by innate immunity ? 1 ln this section, I have raised a number of speculative ideas. However, it should be possible to test these ideas in the post-genornic era. It may be possible, for example to compare the transcripts of mRNA produced by leprosy bacilli in macrophages and in Schwann ce1ls. Thus one could identify genes that are preferentially expressed during growth in Schwann ce1ls and hence might account for this unusual property.
A few conclusions and many more questions
Obtaining a genome sequence should be regarded as a springboard to research on the rnicrobe in questiono I hope in this short review I have shown that this is a time to push forward with researeh into M. leprae, a paradigm of obligate intraeelIular host-dependeney. Fundamental questions for an intraeelIular pathogen about iron metabolism ean be addressed. How the loss of redundaney throughout the genome in eomparison with the tubercle baeilli has resulted in a speeialized pathogen in eontrast to the adaptable M. tubereulosis eomplex is another basie issue in myeobaeteriology. Does the apparent limitation in virulence determinants and celI entry genes (Table 1) eommit M. leprae to gaining access only to its narrow niehe? While two of the three haemolysin genes found in M. tubereulosis, including tlyA , persist in M. leprae, alI four pie genes are lost. Will we find out the role of PPEs and PEs in tubercle bacilli by making eomparisons with M. leprae, a 'natural mutant' for most of them? What else ean we leam about tubercle baeilli by eomparative genomies now we have the leprosy genome? Why eannot M. leprae be grown axenicalIy; do the lesions in energy metabolism only alIow interrupted growth when eonditions are just right in the host? Are media too toxie, at least in aerobie eonditions? With a massive loss of regulatory functions 4 have those that would alIow M. leprae to adapt to axenie eulture been lost? We are now in a position to generate better defined hypotheses. Soon the My eobaeterium uleerans genome will be sequeneed; will eomparisons with this diffieult to grow myeobacterium help us to formulate new hypotheses for M. leprae? FinalIy, we ean design experiments that will provide a better understanding of the interaetion between M. leprae and Sehwann ee1ls. With neurologieal reactions still a major clinieal issue in the treatment of leprosy these are urgent experiments. My eonclusion would be to reeommend the leprosy researeh eommunity develops post-genornie research and investigates the expression of M. leprae genes as a means of addressing the many biologieal questions that still remain.
